Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models

Digestion

Volumn 87, Issue 1, 2013, Pages 6-11

  Miyashita, Tomoharu ^a   Shah, Furhawn A ^c   Miwa, Koichi ^b   Sasaki, Shozo ^a   Nishijima, Koji ^a   Oyama, Katsunobu ^a   Ninomiya, Itasu ^a   Fushida, Sachio ^a   Fujimura, Takashi ^a   Hattori, Takanori ^c   Harmon, John W ^c   Ohta, Tetsuo ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Barrett's esophagus; Carcinogenesis; Chemoprevention; Esophageal adenocarcinoma; Esophageal cancer; Histogenesis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; RABEPRAZOLE;

ANTIINFLAMMATORY ACTIVITY; BARRETT ESOPHAGUS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL HYPERPLASIA; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CPG ISLAND; DUODENUM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; MALIGNANT TRANSFORMATION; METAPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; BASEMENT MEMBRANE; CANCER INCIDENCE; CANCER PREVENTION; DUODENOGASTRIC REFLUX; EXPERIMENTAL NEOPLASM; INFLAMMATION METAPLASIA ADENOCARCINOMA SEQUENCE; RAT; RAT MODEL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DUODENUM; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; METAPLASIA; PROTON PUMP INHIBITORS; RATS;

EID: 84873870477     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000343896     Document Type: Conference Paper

References (22)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 1998; 48: 6-29
2. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31
3. Fein M, Peters JH, Chandrasoma P, Ireland AP, Oberg S, Ritter MP, Bremner CG, Hagen JA, DeMeester TR: Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998; 2: 260-268
4. Lagergren J, Bergström R, Lindgren A, Nyrén O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831
5. Miwa K, Segawa M, Takano Y, Matsumoto H, Sahara H, Yagi M, Miyazaki I, Hattori T: Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer 1994; 70: 185-189
6. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I, Hattori T: Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996; 67: 269-274
7. Fujimura T, Oyama K, Sasaki S, Nishijima K, Miyashita T, Ohta T, Miwa K, Hattori T: Inflammation- related carcinogenesis and prevention in esophageal adenocarcinoma using rat duodenoesophageal reflux models. Cancers 2011; 3: 3206-3224
8. Miyashita T, Ohta T, Fujimura T, Ninomiya I, Fushida S, Hattori T, Miwa K: Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats. Oncol Rep 2006; 15: 1469-1475
9. Pera M, Brito MJ, Poulsom R, Riera E, Grande L, Hanby A, Wright NA: Duodenalcontent reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis 2000; 21: 1587-1591
10. Ireland AP, Peters JH, Smyrk TC, DeMeester TR, Clark GW, Mirvish SS, Adrian TE: Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 1996; 224: 358-370
11. Miyashita T, Miwa K, Fujimura T, Ninomiya I, Fushida S, Shah FA, Harmon JW, Hattori T, Ohta T: The severity of duodeno-esophageal reflux influences the development of different histological types of esophageal cancer in a rat model. Int J Cancer 2012, Epub ahead of print
12. Tatsuta T, Mukaisho K, Sugihara H, Miwa K, Tani T, Hattori T: Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux. Dig Dis Sci 2005; 50: 425-431
13. Marchetti M, Caliot E, Pringault E: Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J Cell Sci 2003; 116: 1429-1436
14. Kazumori H, Ishihara S, Rumi MA, Kadowaki Y, Kinoshita Y: Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 2006; 55: 16-25
15. Souza RF, Krishnan K, Spechler SJ: Acid, bile, and CDX: The ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol 2008; 295: 211-218
16. Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A, Corcoran- Schwartz IM, Wilburn DL, Montgomery EA, Wang JS, Jenkins NA, Copeland NA, Harmon JW, Phillips WA, Watkins DN: Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 2010; 138: 1810-1822
17. Sato F, Meltzer SJ: CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006; 106: 483-493
18. Miyashita T, Shah FA, Marti GP, Wang J, Bonde P, Gibson MK, Ohta T, Montgomery EA, Duncan M, Harmon JW: Rabeprazole impedes the development of reflux-induced esophageal cancer in a surgical rat model. Dig Dis Sci 2011; 56: 1309-1314
19. El-Serag HB: The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002; 31: 421-440
20. Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC: Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 2004; 180: 387-391
21. Csendes A, Bragheto I, Burdiles P, Smok G, Henriquez A, Parada F: Regression of intestinal metaplasia to cardiac or fundic mucosa in patients with Barrett's esophagus submitted to vagotomy, partial gastrectomy and duodenal diversion: A prospective study of 78 patients with more than 5 years of follow up. Surgery 2006; 139: 46-53
22. Das D, Chilton AP, Jankowski JA: Chemoprevention of oesophageal cancer and the AspECT trial. Recent Results Cancer Res 2009; 181: 161-169